CoChat

Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response

Open access
Sahraei, Mahnaz, Chaube, Balkrishna, Liu, Yuting, Sun, Jonathan, Kaplan, Alanna, Price, Nathan L., Ding, Wen, Oyaghire, Stanley, García-Milian, Rolando, Mehta, Sameet, Reshetnyak, Yana K., Bahal, Raman, Fiorina, Paolo, Glazer, Peter M., Rimm, David L., Fernández-Hernando, Carlos, Suárez, Yajaira · 2019 · Journal of Clinical Investigation
Cited by 139

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

microRNA-21 (miR-21) is the most commonly upregulated miRNA in solid tumors. This cancer-associated microRNA (oncomiR) regulates various downstream effectors associated with tumor pathogenesis during all stages of carcinogenesis. In this study, we analyzed the function of miR-21 in noncancer cells of the tumor microenvironment to further evaluate its contribution to tumor progression. We report that the expression of miR-21 in cells of the tumor immune infiltrate, and in particular in macrophages, was responsible for promoting tumor growth. Absence of miR-21 expression in tumor- associated macrophages (TAMs), caused a global rewiring of their transcriptional regulatory network that was skewed toward a proinflammatory angiostatic phenotype. This promoted an antitumoral immune response characterized by a macrophage-mediated improvement of cytotoxic T-cell responses through the induction of cytokines and chemokines, including IL-12 and C-X-C motif chemokine 10. These effects translated to a reduction in tumor neovascularization and an induction of tumor cell death that led to decreased tumor growth. Additionally, using the carrier peptide pH (low) insertion peptide, we were able to target miR-21 in TAMs, which decreased tumor growth even under conditions where miR-21 expression was deficient in cancer cells. Consequently, miR-21 inhibition in TAMs induced an angiostatic and immunostimulatory activation with potential therapeutic implications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci127125

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 139

Metadata

Authors
Sahraei, M., Chaube, B., Liu, Y., Sun, J., Kaplan, A., Price, N. L., Ding, W., Oyaghire, S., García-Milian, R., Mehta, S., Reshetnyak, Y. K., Bahal, R., Fiorina, P., Glazer, P. M., Rimm, D. L., Fernández-Hernando, C., & Suárez, Y.
Venue
Journal of Clinical Investigation
Published
2019-11-11
Volume
129
Issue
12
Pages
5518-5536
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2988072980
Cited by
139
References
12
FWCI
7.21
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response. https://app.cochat.ai/papers/10.1172/jci127125
The paper
Sahraei, M., Chaube, B., Liu, Y., Sun, J., Kaplan, A., Price, N. L., Ding, W., Oyaghire, S., García-Milian, R., Mehta, S., Reshetnyak, Y. K., Bahal, R., Fiorina, P., Glazer, P. M., Rimm, D. L., Fernández-Hernando, C., & Suárez, Y. (2019). Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response. Journal of Clinical Investigation. https://doi.org/10.1172/jci127125

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.